Sal Braico - President and CEO. Before co-founding Flex Biomedical, Sal was the Chief Operating Officer of ConjuGon, an antibacterial biotech company, from 2002 to 2008. He has an MBA from the University of Wisconsin-Madison and a BS in Marine Engineering from the US Merchant Marine Academy. Sal also served as a Lieutenant in the US Naval Reserve.

Mark Grinstaff, PhD - Dr. Grinstaff, a Flex Bio cofounder, is Associate Professor of Biomedical Engineering and Chemistry at Boston University. Prior to BU Mark was Assistant Professor of Chemistry, Ophthalmology, and Biomedical Engineering at Duke University and the Duke Medical Center. Mark received his Ph.D. from the University of Illinois and was an NIH Postdoctoral Fellow at the California Institute of Technology.

Nicholas Mischler, MD - Dr. Mischler is a serial innovator and entrepreneur: developer of five community clinics in Southern Wisconsin and the Meriter Hospital Cancer Clinic, one of the founders of Southern Wisconsin Radiotherapy Center. Nick earned a BA (magna cum laude) from Marquette University, an MD from the University of Pennsylvania, and an MS from the University of Wisconsin. He completed his internal medicine and oncology training at the Universities of Iowa and Wisconsin, respectively, and served in the United States Armed Forces as a Navy flight surgeon. Dr. Mischler is a Fellow of the American College of Physicians and the American College of Physician Executives.

Steven R. Pollock, RPh, MBA - Steve has been in the pharmaceutical industry for over 25 years. He currently is the Vice President of Research and Development at Promentis Pharmaceuticals, Inc., an early-stage pharmaceutical development group focusing on creating new treatments for schizophrenia and other neurological disorders. Steve earned a BS in Pharmacy from the University of Wisconsin, and is a licensed Pharmacist. His MBA was awarded by Western Michigan University.

David C. Sneider, J.D., C.P.A. - David has more than 20 years of domestic and international experience in strategic aspects of finance, mergers and acquisitions, and risk management. David was formerly the CFO of Nerites, the Chief Business Officer of Cellular Dynamics, CFO of NimbleGen Systems Inc., CFO of Third Wave Technologies, and CFO of Tellabs, Inc. He earned a B.B.A. and J.D. from Loyola University of Chicago. His C.P.A. was awarded by the University of Illinois.

Don Urbanowicz - Don Urbanowicz recently retired from Stryker Orthopedics where he led business development since 2001. Mr. Urbanowicz has over 30 years of experience in the medical device industry, including senior positions at Stryker, Aircast, Sofamor Danek, and Smith&Nephew. Mr. Urbanowicz recently started Urbanowicz Consulting, LLC, a medical device advisory firm with a musculoskeletal focus.

Osteoarthritis (OA) - Incurable and painful disease in which cartilage and synovial fluid break down inside of joints.